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Abstract:  The role of vascular risk factors in glaucoma is increasingly being supported by the literature, with the 
association between low ocular perfusion pressure (PP) and glaucoma being the most consistent result. However, we need 
to be cautious when interpreting these results and consider all possible confounders in the observed associations. While 
we assess PP through its principal components, the weight of intraocular pressure (IOP) and blood pressure (BP) in the PP 
equation remains unknown. Also, the role of PP in glaucoma needs to be elucidated with regards to IOP and BP 
fluctuation during the 24hour period and the effect of IOP-lowering and BP-lowering treatment. The complexity of the 
interaction of PP with other potential risk factors for glaucoma means that PP cannot be currently considered in the 
assessment of an individual patient. The role of PP in glaucoma warrants further research and randomized clinical trials 
assessing PP should include vision and/or structure preservation as end-points and ideally address all of the above issues. 
INTRODUCTION 
  Intraocular pressure (IOP) reduction is currently the only 
treatment available for decreasing the risk of glaucoma 
progression [1]. However, glaucoma may continue to 
progress despite IOP reduction to targeted levels
 [2-4]. This 
indicates that factors other than IOP may play an important 
role in the pathogenesis of glaucoma. The role of vascular 
risk factors in glaucoma, particularly ocular perfusion 
pressure (PP), is being increasingly supported by the 
literature. PP is defined as the difference between arterial 
and venous pressure, which, in the eye, by convention equals 
IOP. Therefore, blood pressure (BP) and IOP are the 
principal components of ocular PP (PP=BP-IOP), which 
determines the nutritive delivery of arterial blood to capillary 
beds. Ocular hemodynamics in young healthy individuals, 
are autoregulated to maintain constant blood supply to ocular 
tissues, despite changes in PP [5]. However in glaucoma, 
there is the hypothesis of a defective autoregulation, 
resulting in ischemic damage and reperfusion injury [6]. In a 
case-control study by Gherghel et al, lower ocular PP was 
associated with hemodynamic alterations in progressive 
glaucoma patients [7]. Interestingly, this association was not 
found in nonprogressive glaucoma patients or healthy 
individuals. 
FROM PP TO ITS PRINCIPAL COMPONENTS: BP 
AND IOP 
  In several population-based studies BP and IOP have 
been reported to be positively associated in both healthy 
individuals [8-11] and open-angle glaucoma (OAG) subjects 
[12-17]. In some studies this association was found for 
systolic BP, but not for diastolic BP [10, 11]. Also, most 
studies report a positive association between age and IOP [8, 
9, 12, 13, 18, 19], while a negative association has been 
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reported by few Japanese studies [11, 20]. In addition, a 
positive association has been reported between age and BP 
[21, 22]. Based on the above, one may suggest that age is a 
confounder in the BP-IOP relationship. However, in most 
studies the association of BP and IOP remained statistically 
significant after adjustment for age [8, 9, 12-17]. Therefore, 
it seems that the association of BP with IOP is independent 
of age. Although evidence may suggest an association 
between BP and IOP, the magnitude of IOP change 
associated with BP change is small, on the rate of 0.2-
0.4mmHg/10mmHg [23]. 
  Because increased IOP and glaucoma are associated, it 
may be expected that increased BP and glaucoma are also 
associated, through the BP-IOP relationship. However, 
hypertension has not been consistently reported as a risk 
factor for glaucoma [12, 13, 24-28]. An association between 
hypertension and glaucoma has been initially reported by 
non population-based studies [24, 25]. Later, some 
population-based studies confirmed this association [12, 13, 
26], while others did not [27, 28]. Among studies confirming 
this association, results were adjusted for IOP in the 
Rotterdam Study [13] and the Blue Mountains Eye Study 
[26], while in the Egna-Neumarkt Study they were not [12]. 
  Although, there is enough evidence on the IOP-glaucoma 
relationship and the BP-IOP relationship, the BP-IOP-
glaucoma interrelationship is more complex and remains 
unclear. In addition, one should consider the role of age in 
the above interrelationship. In the Baltimore Eye Survey, the 
association of BP and OAG depended on age [28]. 
Specifically, young hypertensives were less likely to have 
OAG compared to non-hypertensives, while older 
hypertensives were more likely to have OAG compared to 
non-hypertensives [28]. It is possible that age is a surrogate 
for duration of hypertension and that autoregulative 
mechanisms may be compromised after years of exposure to 
hypertension, and thus may predispose to OAG [29]. 44    The Open Ophthalmology Journal, 2009, Volume 3  Topouzis and Founti 
THE ROLE OF PP IN GLAUCOMA – A RISK FACTOR 
FOR GLAUCOMA PREVALENCE, INCIDENCE AND 
PROGRESSION 
  Low diastolic PP has been consistently associated with 
increased glaucoma prevalence in population-based studies. 
In the Baltimore Eye Survey [28], the Barbados Eye Study 
[27] and the Rotterdam Study [30] low diastolic PP was a 
risk factor for glaucoma prevalence. Having findings to the 
same direction, the Egna-Neumarkt Study [12] and the 
Proyecto VER [31] found that glaucoma prevalence 
decreases progressively with increased diastolic PP. 
  Further to that, low diastolic PP has been associated with 
increased glaucoma incidence. In the Barbados Eye study, a 
population-based cohort study of 3222 African origin 
participants with a follow-up of over 9 years, OAG incidence 
was 4.4% [32]. Among baseline factors included in the 
analysis, all lower PPs, meaning systolic, diastolic and mean 
PP, were associated with an increased risk of OAG 
incidence. In addition, the Early Manifest Glaucoma Trial 
(EMGT), a prospective randomized clinical trial (RCT) of 
255 Caucasian participants with a median follow-up of 8 
years, evaluated risk factors for progression of manifest 
OAG [33]. Overall progression was 67%, while baseline 
systolic PP  125 mm Hg was a risk factor for OAG 
progression (OR, 1.42; 95% CI, 1.04-1.94). 
  Although findings from cross-sectional studies and the 
EMGT are consistent on low PP as risk factor for glaucoma, 
we need to be cautious when interpreting these results. In all 
cross-sectional studies reporting low PP as a risk factor for 
glaucoma prevalence results were not adjusted for IOP-
lowering and BP-lowering treatment. In addition, even 
though results were adjusted for IOP, IOP-lowering and BP-
lowering treatment in the incidence report of the Barbados 
Eye Study and the EMGT, residual confounding may still 
exist. 
PP: A TRICKY VARIABLE WITH REGARDS TO IOP 
AND BP 
  PP can be affected by both its components, meaning IOP 
and BP. However, among the two “players” we do not know 
who is really playing the game. It could be only IOP, only 
BP or a combination of both. Even if we assume the third 
case which seems more reasonable, we do not know the 
weight of each variable to PP and whether it is the same for 
the whole IOP spectrum. For example, the Egna-Neumarkt 
Study did not find an association between low diastolic PP 
and increased glaucoma prevalence in normal-tension 
glaucoma [12]. According to the authors, this may be related 
to the limited number of cases in the normal-tension 
glaucoma group. However, this might also be because of 
different pathogenic mechanisms in normal-tension 
compared to high-tension glaucoma or simply because PP 
cannot be very low in normal-tension glaucoma due to low 
IOP values. This hypothesis may also be supported by the 
Rotterdam Study results, where PP<50mmHg was positively 
associated with high-tension glaucoma, while it was 
inversely associated with normal-tension glaucoma (OR, 
0.25; 95% CI, 0.10-0.63) [30]. 
  Further to that, there are few reports on how IOP and BP 
fluctuate at different time-points during the 24hour period 
[34, 35] and therefore we do not know the result of IOP and 
BP fluctuation on PP. In a recent report by Kida T et al. PP 
fluctuation was estimated based on both IOP and BP 
measurements during the 24-hour period [35]. However, this 
study involved only healthy eyes, while all measurements 
were performed in the sitting position. More studies will be 
needed to determine the effect of IOP and BP fluctuation on 
PP in glaucoma subjects and in real-life conditions. 
  In addition, evidence suggests that PP can be influenced 
by high IOP alone or by IOP-lowering treatment. In the 
Barbados Eye Study and the EMGT, results were adjusted 
for IOP, IOP-lowering and BP-lowering treatment [32, 33]. 
However, one may not exclude residual confounding. It is 
possible that there is a different significance of BP 
depending on the IOP. In the EMGT subgroup analyses with 
regards to IOP, systolic BP 160 mmHg was associated with 
progression in patients with baseline IOP <21 mmHg [33]. 
However, only systolic PP 125mmHg, but not systolic BP 
160 mm Hg was associated with progression in patients 
with higher baseline IOP. This suggests that the association 
was possibly driven by high IOP, leading to lower systolic 
PP. 
  Another issue that should be considered in order to 
determine the role of PP in glaucoma is the effect of BP-
lowering treatment. The same level of BP may have a 
different significance in those treated for hypertension 
compared to non-hypertensive subjects. In a Thessaloniki 
Eye Study report involving 232 non-glaucoma subjects 
examined with the Heidelberg Retina Tomograph, low 
diastolic PP, low diastolic BP and the use of BP-lowering 
treatment were significantly associated with increased 
cupping and decreased rim area only in subjects with 
decreased diastolic BP (<90 mm Hg) as a result of 
antihypertensive treatment [36]. Similarly, in the Rotterdam 
Study low diastolic PP was associated with increased 
glaucoma prevalence only in subjects treated for 
hypertension [30]. The type and duration of BP-lowering 
treatment may also contribute to glaucoma risk. In the 
European Glaucoma Prevention Study the use of diuretics 
was an independent risk factor for OAG incidence (OR, 
2.41; 95% CI, 1.12-5.19) [37]. This suggests that the type of 
BP-lowering treatment may be an additional variable to 
consider when assessing PP. 
CONCLUSION 
  Evidence from the literature may support an age-
independent positive association between BP and IOP. 
However, there is still controversy on the role of 
hypertension in glaucoma, while the interrelationship 
between BP, IOP and glaucoma remains unclear. 
Understanding PP and its role in glaucoma could provide 
some insight into how these variables interfere and 
ultimately increase our knowledge on glaucoma 
pathogenesis. However, there are several factors which 
should be considered when interpreting the observed 
associations related to PP. The apparent complexity of the 
interaction of PP with other potential risk factors for 
glaucoma suggests that PP warrants further research and 
cannot be currently considered in the assessment of an 
individual patient. Perfusion Pressure in Glaucoma  The Open Ophthalmology Journal, 2009, Volume 3    45 
  In order to be able to introduce PP in clinical practice, we 
should first determine and quantify the role of PP in 
glaucoma risk. This would mostly require RCTs specifically 
designed to address PP. Such RCTs should include vision 
and/or structure preservation as end-points and involve long-
term follow-up. 
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